THG HANOVER INSURANCE GROUP, INC. Insider Trading

THG CEO John C Roche sells 8,358 shares for $1,619,266.14 via scheduled 10b5-1 plan; holds 141,010 post-transaction

John C Roche executed 3 separate sales totaling 8,358 shares for $1,619,266.14 at an average price of $193.74 per share on 2026-05-20, reducing his holdings from 149,368 to 141,010 shares (-5.6%). The sales were conducted under a pre-arranged 10b5-1 trading plan adopted 2025-11-19, making them scheduled transactions rather than discretionary decisions. At the current price of $195.58, the stock sits near its 52-week high of $199.59 and has climbed 8.2% over the past 30 days and 11.2% over 90 days. Historical outcomes from Roche's prior trades at THG show mixed results—a sell on 2025-04-01 resulted in 30-day and 90-day declines, while three earlier sells in March 2025 yielded modest positive returns—providing limited directional context for this scheduled disposition.

EVP Dennis Kerrigan sells 6,262 THG shares at $192.99; retains 11,987 shares post-transaction

Dennis Francis Kerrigan, Executive Vice President, sold 6,262 shares of Hanover Insurance Group at $192.99 on 2026-05-20, reducing his holdings by 34.3% to 11,987 shares. The sale occurred at a price 2.0% below the 52-week high of $199.59, while the stock has advanced 8.2% over the prior 30 days and 11.2% over 90 days. The company trades at a P/E of 9.49 with recent quarterly revenue of $1,701,400,000.00 and net income of $186,800,000.00, reflecting solid fundamentals. The transaction represents a substantial reduction in his stake, though retention of 11,987 shares indicates continued material ownership in the firm.

Hanover Insurance CEO Roche sells 5,251 shares for $1.0M via scheduled 10b5-1 plan

John C. Roche, President and CEO of Hanover Insurance Group, executed 4 separate sales totaling 5,251 shares for $1,040,031.25 at a blended average price of $198.06, reducing his holdings from 146,261 to 141,010 shares (-3.6%). The transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2025-11-19, meaning it is scheduled rather than discretionary. His prior trades at THG show mixed near-term outcomes: one April 2025 sale yielded -5.5% over 30 days, while three March 2025 sales ranged from +1.4% to +2.5% over the same period. With the stock at $193.79 current price and the insider's blended sale price at $198.06, the transaction executed near the upper end of the 52-week range ($160.70–$199.59), though no timing characterization is applicable given the scheduled nature of the plan.

Denise Lowsley (EVP, Hanover Insurance) sold 4,175 shares for $800,472.75 on 2026-05-14, cutting holdings by 51.8%

Denise Lowsley executed 2 separate sales on 2026-05-14, selling 4,175 shares at $115.35 and 4,175 shares at $191.73, totaling $800,472.75 and reducing her holdings from 8,057 shares to 3,882 shares. Her prior sale at THG on 2025-08-01 posted 30-day +3.2% and 90-day +1.2% returns. The stock is currently at $194.64, within 0.7% of its 52-week high of $193.32, with 30-day and 90-day gains of +9.9% and +13.3% respectively. Lowsley's cross-ticker track record shows 0 of 1 prior sells were well-timed at the 90-day mark, with an average 90-day return after sells of +1.2%.